These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5978728)

  • 1. Activity of combinations of uracil mustard (NSC-34462) and 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone) [KTS; NSC-82116] against murine tumors.
    Petering HG; Buskirk HH; Crim JA
    Cancer Chemother Rep; 1966 Nov; 50(8):557-64. PubMed ID: 5978728
    [No Abstract]   [Full Text] [Related]  

  • 2. Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors.
    Mihich E; Nichol CA
    Cancer Res; 1965 Oct; 25(9):1410-6. PubMed ID: 5217028
    [No Abstract]   [Full Text] [Related]  

  • 3. The antitumor activity of Cu(II)KTS, the copper (II) chelate of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone).
    Crim JA; Petering HG
    Cancer Res; 1967 Jul; 27(7):1278-85. PubMed ID: 4952520
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of dietary mineral supplements of the rat on the antitumor activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone).
    Petering HG; Buskirk HH; Crim JA
    Cancer Res; 1967 Jun; 27(6):1115-21. PubMed ID: 6027202
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of B vitamin and protein intake of the rat on the antitumor activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone).
    Crim JA; Buskirk HH; Petering HG
    Cancer Res; 1967 Jun; 27(6):1109-14. PubMed ID: 6027201
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of dibromodulcitol (NSC 104800) on intravenously induced cytemia of rats.
    Németh L
    Neoplasma; 1971; 18(5):533-7. PubMed ID: 5119525
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of the growth of sarcoma 180 ascites cells by combinations of inhibitors of nucleic acid biosynthesis and the cupric chelate of kethoxal bis-(thiosemicarbazone).
    Sartorelli AC; Booth BA
    Cancer Res; 1967 Sep; 27(9):1614-9. PubMed ID: 6051275
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antineoplastic and curative antileukemic activity of 1,4-benzoquinone guanylhydrazone thiosemicarbazone and its hydrochloride on in vivo murine models].
    Gutsche W; Schulze W; Jungstand W; Wohlrabe K
    Pharmazie; 1983 Feb; 38(2):105-7. PubMed ID: 6856662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study of antitumor action of rubomycin in combination with some cytostatic compounds].
    Rossolimo OK; Lepeshkina GN
    Antibiotiki; 1967 Mar; 12(3):206-12. PubMed ID: 4969789
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the selectivity of antitumor agents.
    Garattini S; Guaitani A; Nanni E; Palma V
    Cancer Res; 1967 Dec; 27(12 Pt 2):1309-437. PubMed ID: 4295303
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on a spectrum of mouse and rat tumors.
    Mihich E; Gelzer J
    Cancer Res; 1968 Mar; 28(3):553-8. PubMed ID: 4966648
    [No Abstract]   [Full Text] [Related]  

  • 12. Metal complexes of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone) and related ligands as antitumor agents.
    Van Giessen GJ; Petering HG
    J Med Chem; 1968 Jul; 11(4):695-9. PubMed ID: 5671226
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental and clinical studies of the antitumor activity of 1-methyl-1-nitrosourea (NSC-23909).
    Emanuel NM; Vermel EM; Ostrovskaya LA; Korman NP
    Cancer Chemother Rep; 1974; 58(2):135-48. PubMed ID: 4830495
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental findings concerning the anti-tumor properties of nordopan glucosides].
    Popov DV; Platonova GN; Studentsov EP; Larionov LF
    Biull Eksp Biol Med; 1973 May; 75(5):73-5. PubMed ID: 4778694
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytostatic effect of vinylogous nitrogen mustard carbonamidium salts against transplanted tumors in an automatic preliminary test and a sequential test program].
    Gutsche W; Jungstand W; Wohlrabe K; Fischer GW; Lohs K
    Arch Geschwulstforsch; 1972; 39(2):121-7. PubMed ID: 5065117
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ineffectiveness of a drug combination on Yoshida sarcoma and Walker carcinosarcoma 256 of the rat and on Ehrlich carcinoma of the mouse].
    Zeller WJ; Wiessler M; Adzersen KH
    Arzneimittelforschung; 1972 Mar; 22(3):575-7. PubMed ID: 5067931
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of heavy metals on the in vitro cytotoxicity of 3-ethoxy-2-oxobutyraldehyde bis (thiosemicarbazone) and related compounds.
    Van Giessen GJ; Crim JA; Petering DH; Petering HG
    J Natl Cancer Inst; 1973 Jul; 51(1):139-46. PubMed ID: 4720869
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the effect of tumor type and route of administration on the antitumor activity of the amino acid mimosine (NSC-69188).
    DeWys WD; Hall TC
    Cancer Chemother Rep; 1973 Feb; 57(1):41-9. PubMed ID: 4704102
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental findings concerning the antineoplastic drug fluordopan].
    Larionov LF; Bukharova IK
    Vopr Onkol; 1971; 17(5):78-81. PubMed ID: 4333111
    [No Abstract]   [Full Text] [Related]  

  • 20. [Time factor in evaluating antineoplastic agents].
    Syrkin AB
    Farmakol Toksikol; 1972; 35(1):75-9. PubMed ID: 5011523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.